The spatial and temporal control of gene activation and silencing is essential for proper morphogenesis of developing organs. Recently, miRNA (microRNA)-mediated gene silencing has emerged as a major mechanism of gene silencing in several species. It has been estimated that at least 1% of the transcripts in the genome code for miRNAs, and that miRNA have at least 20-30% of the coding genes as their targets. Genetic inactivation of components of the miRNA-mediated gene silencing machinery, such as Dicer, Argonautes, or of specific miRNAs in multiple organisms support the idea that miRNA-mediated gene regulation is essential in the developing mouse. The role of miRNA-mediated gene silencing in complex branching organs, such as the lung, has not been explored. The objective of this application is to explore the role of miRNA-mediated gene silencing in lung development. The central hypothesis is that miRNAs can selectively turn expression of target genes off to allow normal morphogenesis and differentiation. To test this hypothesis we propose to: Identify and characterize expression of microRNAs in the developing lung (Aim 1), investigate silencing of specific miRNA targets and its consequences in lung cell cultures in vitro and in vivo (Aim 2), characterize the function of the RISC complex component Argonaute-1 in the developing lung (Aim 3). Relevance of the research to public health: Loss of control of normal gene expression has been associated with abnormal development and with many human diseases including cancer. Micro RNAs have been recently emerged as a major mechanism to control gene expression in normal development. Little is known how these molecules function in the embryonic lung and what genes they regulate. This study will provide insights into this issue and will help to understand mechanism of human diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL081800-04S1
Application #
7837471
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Blaisdell, Carol J
Project Start
2009-07-01
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
4
Fiscal Year
2009
Total Cost
$246,322
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Cushing, Leah; Costinean, Stefan; Xu, Wei et al. (2015) Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature. PLoS Genet 11:e1005238
Cushing, Leah; Jiang, Zhihua; Kuang, Pingping et al. (2015) The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases. Am J Respir Cell Mol Biol 52:397-408
Jiang, Zhihua; Cushing, Leah; Ai, Xingbin et al. (2014) miR-326 is downstream of Sonic hedgehog signaling and regulates the expression of Gli2 and smoothened. Am J Respir Cell Mol Biol 51:273-83
Jiang, Zhihua; Yu, Nan; Kuang, Pingping et al. (2012) Trinucleotide repeat containing 6a (Tnrc6a)-mediated microRNA function is required for development of yolk sac endoderm. J Biol Chem 287:5979-87
Chen, Felicia; Cao, Yuxia; Qian, Jun et al. (2010) A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium. J Clin Invest 120:2040-8
Wu, Junjie; Qian, Jun; Li, Chun et al. (2010) miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9:1809-18